Synapse - Guenther Koehne

Results (194)

T-cell depleted allogeneic HSCT for patients with relapsed, high-risk multiple myeloma permits long-lasting remissions in the absence of graft-versus-host disease and provides a platform for adoptive immunotherapeutic approaches

Meeting Abstract

Koehne, G.; Devlin, S.; Landau, H.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; Chung, D. J.; Bravo, C.; Giralt, S. A.
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

A novel reduced intensity conditioning regimen for patients with high risk hematologic malignancies undergoing conventional allogeneic stem cell transplantation

Meeting Abstract

Hobbs, G.; Kaur, N.; Ponce, D. M.; Hilden, P.; Castro-Malaspina, H.; Giralt, S. A.; Goldberg, J. D.; Papadopoulos, E.; Jakubowski, A. A.; Sauter, C. S.; more...
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Generation and characterization of a third party GMP grade bank of CMV specific T-cells for adoptive immunotherapy of CMV infections in recipients of HSCT from cord blood or seronegative donors

Meeting Abstract

Hasan, A. N.; Doubrovina, E. S.; Koehne, G.; Prockop, S. E.; O'reilly, R.
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Phase 1 trial of carfilzomib + melphalan (CarMel) conditioning and autologous hematopoietic stem cell transplantation (AHSCT) for relapsed multiple myeloma (MM)

Meeting Abstract

Costa, L. J.; Landau, H.; Venkata, J. K.; Kang, Y. B.; Koehne, G.; Chung, D. J.; Lendvai, N.; Bentz, T.; Giralt, S. A.
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Immune reconstitution after autologous stem cell transplantation for multiple myeloma

Meeting Abstract

Chung, D. J.; Pronschinske, K. B.; Shyer, J. A.; Wu, V.; Hassoun, H.; Landau, H.; Lendvai, N.; Lesokhin, A. M.; Koehne, G.; Giralt, S. A.; more...
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Double-unit cord blood (CB) transplantation combined with haplo-identical CD34+ cells results in 100% CB engraftment with enhanced myeloid recovery

Meeting Abstract

Barker, J. N.; Ponce, D. M.; Dahi, P.; Devlin, S.; Evans, K.; Lubin, M.; Meagher, R.; Castro-Malaspina, H.; Goldberg, J. D.; Jakubowski, A. A.; more...
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

A Phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with BCell lymphoid malignancies: Favorably durable event-free survival in chemosensitive patients

Journal Article

Sauter, C. S.; Barker, J. N.; Lechner, L.; Zheng, J.; Devlin, S. M.; Papadopoulos, E. B.; Perales, M. A.; Jakubowski, A. A.; Goldberg, J. D.; Koehne, G.; more...
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Multiparameter flow cytometry for detection of minimal residual disease in multiple myeloma after T-cell depleted allogeneic stem cell transplant

Meeting Abstract

Kosuri, S.; Smith, K. M.; Kuk, D.; Devlin, S. M.; Maslak, P. G.; Giralt, S.; Koehne, G.
Blood (2013)

Fulltext@MSK | Save

The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS

Meeting Abstract

Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Malloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
Blood (2013)

Fulltext@MSK | Save

Multiple copies of MLL is the most commonly detected cytogenetic abnormality in newly diagnosed multiple myeloma and may modify disease risk

Meeting Abstract

Landry, C.; Londono, D.; Devlin, S. M.; Lesokhin, A.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; Jhanwar, S. C.; Giralt, S. A.; more...
Blood (2013)

Fulltext@MSK | Save